Methylprednisolone with Warfarin Interaction Details


Brand Names Associated with Methylprednisolone

  • Medrol®
  • Methylprednisolone

Brand Names Associated with Warfarin

  • Coumadin®
  • Jantoven®
  • Warfarin

Medical Content Editor
Last updated Dec 03, 2023


Curious for more information about this interaction?

Ask our pharmacists directly!

Reach out to us

Interaction Effect

Increased risk of bleeding or diminished effects of warfarin


Interaction Summary

Concomitant use of warfarin and an adrenocortical steroid, such as methylPREDNISolone, has been associated with increased and decreased prothrombin time/INR responses. In a retrospective review of 32 patient on long-term warfarin therapy, higher INR values following concurrent corticosteroid therapy compared to INR values prior to corticosteroid initiation were reported . Monitoring of coagulation indices is recommended when methylPREDNISolone is administered with an anticoagulant, such as warfarin .


Severity

Moderate


Onset

Delayed


Evidence

Established


How To Manage Interaction

Prothrombin time/INR should be monitored closely if methylPREDNISolone and warfarin are taken concomitantly, especially during medication initiation or discontinuation. Increased and decreased prothrombin time/INR responses have been reported with concomitant use of warfarin and adrenocortical steroids. When methylPREDNISolone is administered with warfarin, it is recommended that the warfarin dose be adjusted as necessary to maintain desired response .


Mechanism Of Interaction

Unknown


Literature Reports

A) In a retrospective review of 32 patient encounters, patients on long-term warfarin therapy had higher INR values following concurrent corticosteroid therapy compared to INR values prior to corticosteroid initiation. Patients on stable anticoagulation therapy with short term corticosteroid therapy were evaluated with INR measurements obtained 30 days prior to corticosteroid initiation (pre-INR) and during corticosteroid therapy or within 14 days of discontinuation (post-INR). Patients were given corticosteroids for an average of 9 days (6 to 30 days) with prednisone (50%) and methylPREDNISolone (50%) accounting for the oral corticosteroids the patients were administered. The mean pre-INR value was 2.33 +/- 0.37 (measured 11.9 +/- 7.1 days after corticosteroid initiation) compared to the mean post-INR value of 3.57 +/- 1.07 (measured 6.7 +/- 3.3 days after first dose of corticosteroid) (p less than 0.001). Post-INR measurements above the desired INR goal range were noted in 62.5% of patient encounters, and dose reductions/modifications were required in 50% (n=16) of patient encounters. One adverse event of mild epistaxis was reported. The authors propose that this drug interaction is due to altered liver metabolism of warfarin by corticosteroids .

Methylprednisolone Overview

  • Methylprednisolone, a corticosteroid, is similar to a natural hormone produced by your adrenal glands. It is often used to replace this chemical when your body does not make enough of it. It relieves inflammation (swelling, heat, redness, and pain) and is used to treat certain forms of arthritis; skin, blood, kidney, eye, thyroid, and intestinal disorders (e.g., colitis); severe allergies; and asthma. Methylprednisolone is also used to treat certain types of cancer.

  • This medication is sometimes prescribed for other uses; ask your doctor or pharmacist for more information.

See More information Regarding Methylprednisolone

Warfarin Overview

  • Warfarin is used to prevent blood clots from forming or growing larger in your blood and blood vessels. It is prescribed for people with certain types of irregular heartbeat, people with prosthetic (replacement or mechanical) heart valves, and people who have suffered a heart attack. Warfarin is also used to treat or prevent venous thrombosis (swelling and blood clot in a vein) and pulmonary embolism (a blood clot in the lung). Warfarin is in a class of medications called anticoagulants ('blood thinners'). It works by decreasing the clotting ability of the blood.

See More information Regarding Warfarin

Return To Our Drug Interaction Homepage


Feedback, Question Or Comment About This Information?

Ask , our medical editor, directly! He's always more than happy to assist.


Definitions

Severity Categories

Contraindicated

These drugs, generally, should not be used together simultaneously due to the high risk of severe adverse effects. Combining these medications can lead to dangerous health outcomes and should be strictly avoided unless otherwise instructed by your provider.


Major

This interaction could result in very serious and potentially life-threatening consequences. If you are taking this drug combination, it is very important to be under close medical supervision to minimize severe side effects and ensure your safety. It may be necessary to change a medication or dosage to prevent harm.


Moderate

This interaction has the potential to worsen your medical condition or alter the effectiveness of your treatment. It's important that you are monitored closely and you potentially may need to make adjustments in your treatment plan or drug dosage to maintain optimal health.


Minor

While this interaction is unlikely to cause significant problems, it could intensify side effects or reduce the effectiveness of one or both medications. Monitoring for changes in symptoms and your condition is recommended, and adjustments may be made if needed to manage any increased or more pronounced side effects.


Onset

Rapid: Onset of drug interaction typically occurs within 24 hours of co-administration.

Delayed: Onset of drug interaction typically occurs more than 24 hours after co-administration.


Evidence

Level of documentation of the interaction.

Established: The interaction is documented and substantiated in peer-reviewed medical literature.

Theoretical: This interaction is not fully supported by current medical evidence or well-documented sources, but it is based on known drug mechanisms, drug effects, and other relevant information.


How To Manage The Interaction

Provides a detailed discussion on how patients and clinicians can approach the identified drug interaction as well as offers guidance on what to expect and strategies to potentially mitigate the effects of the interaction. This may include recommendations on adjusting medication dosages, altering the timing of drug administration, or closely monitoring for specific symptoms.

It's important to note that all medical situations are unique, and management approaches should be tailored to individual circumstances. Patients should always consult their healthcare provider for personalized advice and guidance on managing drug interactions effectively.


Mechanism Of Interaction

The theorized or clinically determined reason (i.e., mechanism) why the drug-drug interaction occurs.


Disclaimer: The information provided on this page is for informational purposes only and should not be considered medical advice. Always consult with a qualified healthcare professional regarding your specific circumstances and medical conditions.

Where Does Our Information Come From?

Information for our drug interactions is compiled from several drug compendia, including:

The prescribing information for each drug, as published on DailyMED, is also used. 

Individual drug-drug interaction detail pages contain references specific to that interaction. You can click on the reference number within brackets '[]' to see what reference was utilized.

The information posted is fact-checked by HelloPharmacist clinicians and reviewed quarterly.